Market revenue in 2024 | USD 4,562.3 million |
Market revenue in 2030 | USD 4,686.1 million |
Growth rate | 0.9% (CAGR from 2025 to 2030) |
Largest segment | Antivirals |
Fastest growing segment | Antifungals |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Antibacterials, Antivirals, Antifungals |
Key market players worldwide | Pfizer Inc, Abbott Laboratories, Gilead Sciences Inc, Bristol-Myers Squibb Co, Merck & Co Inc, Sandoz Group AG ADR, B. Braun, Novo Holdings, Mankind Pharma, Bayer AG, AstraZeneca PLC, Boehringer Ingelheim Pharma |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anti-infective agents market will help companies and investors design strategic landscapes.
Antivirals was the largest segment with a revenue share of 42.7% in 2024. Horizon Databook has segmented the Middle East & Africa anti-infective agents market based on antibacterials, antivirals, antifungals covering the revenue growth of each sub-segment from 2018 to 2030.
The anti-infective agents market in the Middle East and Africa (MEA) is witnessing substantial growth, driven by an increasing prevalence of infectious diseases and heightened awareness of their impact on public health.
Conditions such as tuberculosis, malaria, HIV/AIDS, and various bacterial infections are widespread in parts of the region, underscoring the urgent need for effective treatment solutions. The Middle East and North Africa (MENA) region is one of only two areas globally where HIV cases are increasing.
Awareness campaigns, often supported by both government and non-governmental organizations, play a vital role in educating communities about infection prevention and encouraging the use of prescribed treatments.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa anti-infective agents market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa anti-infective agents market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account